These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11750333)

  • 21. Cyclosporine neoral monitoring and its correlation with the "area under the curve".
    Sabbatiello R; Sgrosso JL; Schiavelli R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3378. PubMed ID: 8962317
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of cyclosporine on the development of immunosuppressive therapy: perspective from a transplant nephrologist involved with the development of C2.
    Cole E; Deshpande R
    Transplant Proc; 2004 Mar; 36(2 Suppl):408S-413S. PubMed ID: 15041376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine blood concentration at 2 hours (C(2)) from drug ingestion as the best single indicator of adequate cyclosporine immunosuppression in renal allograft recipients--a four-year follow-up.
    Baczkowska T; Serafinowicz A; Kukuła K; Nowacka-Cieciura E; Cieciura T; Deborska D; Gałazka Z; Rowiński W; Szmidt J; Durlik M; Lao M
    Transplant Proc; 2002 Mar; 34(2):556-7. PubMed ID: 12009622
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case study: de novo application of Neoral in renal transplantation.
    Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G; Perico N; Gaspari F
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictive value of cyclosporine blood levels during the absorption phase to estimate the area under the curve in stable renal transplant patients.
    Sabaté I; Calzada P; Gil-Vernet S; Fulladosa X; Baró S; González C; Castro MJ; Castelao AM; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):140-1. PubMed ID: 11959224
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W; Chen Y; Xing J; Tian P
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract]   [Full Text] [Related]  

  • 31. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 32. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetic study of neoral versus Sandimmun in Japanese stable renal allograft recipients.
    Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H
    Transplant Proc; 2001 Jun; 33(4):2541-4. PubMed ID: 11406243
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative pharmacokinetic study of Neoral vs Sandimmun in Japanese stable renal allograft recipients.
    Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H
    Transplant Proc; 1999 Nov; 31(7):3089-92. PubMed ID: 10610595
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract]   [Full Text] [Related]  

  • 36. Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients.
    Cortinovis M; Gotti E; Trillini M; Carrara F; Gaspari F; Ruggenenti P; Remuzzi G; Perico N
    Nephron; 2017; 135(3):173-180. PubMed ID: 27941326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
    Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J
    Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of Neoral in pediatric renal transplantation.
    Ettenger RE; Smith HT; Kaiser B; Cooney GF; Summerauer J; Alexander S; Moulton LT; Choc MG; Wong RL
    Transplant Proc; 1996 Aug; 28(4):2257-8. PubMed ID: 8769217
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
    Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
    Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
    [No Abstract]   [Full Text] [Related]  

  • 40. Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.
    Goh BL; Jalil R; Koh SN; Chua CT; Tan SY
    Transplant Proc; 1998 Nov; 30(7):3535-6. PubMed ID: 9838548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.